Clinical Research Directory

Inclusion Criteria: * Age ≥ 18 years. * Signed informed consent form * Endovascular indication for treatment based on treating physician's best medical judgment. * Intend for no other stents to be placed in the same peripheral vessel(s) targeted for VBX Stent Graft placement. * Willingness of the patient to adhere to standard of care follow-up requirements. Exclusion Criteria: * Known hypersensitivity to heparin or a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. * Participation in concurrent research study or registry which may confound registry results, unless approved by Gore. * Pregnant or breast-feeding female at time of informed consent signature. * Life expectancy \< 12 months due to comorbidities. * Use of the VBX Stent Graft is for the treatment of de novo iliac occlusive disease. * Use of the VBX Stent Graft is for the treatment of aortic coarctations. * Use of the VBX Stent Graft in the coronary, pulmonary, carotid, vertebral, isolated infrarenal aortic, or vena cava vessels.